Laman UtamaPHIO • NASDAQ
add
Phio Pharmaceuticals Corp
$1.58
Selepas Waktu Dagangan:(0.63%)-0.0100
$1.57
Tutup: 5 Nov, 7:54:33 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$1.63
Julat hari
$1.51 - $1.69
Julat tahun
$0.97 - $9.79
Permodalan pasaran
9.05J USD
Bilangan Purata
5.58J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 1.24J | 17.84% |
Pendapatan bersih | -2.17J | -17.33% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | — | — |
EBITDA | -2.31J | -20.67% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 10.78J | 129.35% |
Jumlah aset | 11.30J | 113.39% |
Jumlah liabiliti | 1.21J | -20.81% |
Jumlah ekuiti | 10.10J | — |
Syer tertunggak | 5.73J | — |
Harga kepada buku | 0.78 | — |
Pulangan pada aset | -46.66% | — |
Pulangan pada modal | -51.85% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -2.17J | -17.33% |
Tunai daripada operasi | -2.54J | -42.94% |
Tunai daripada pelaburan | -3.00K | — |
Tunai daripada pembiayaan | 40.00K | — |
Perubahan bersih dalam tunai | -2.50J | -40.86% |
Aliran tunai bebas | -1.82J | -61.47% |
Perihal
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Diasaskan
2011
Tapak web
Pekerja
5
